Skip to content
10-K/A

Annual Report

HASCO Medical, Inc.

0001553350-14-000187

← back to feed
Filed
Feb 19, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 18, 2013 988.19M sh
Stock Issued FY 2012 · Dec 31, 2012 2.81M sh
Stock Issued FY 2012 · Dec 31, 2011 6.67M sh
Shares Diluted FY 2012 · Dec 31, 2012 948.36M sh
Shares Diluted FY 2012 · Dec 31, 2011 759.96M sh
Capex restated FY 2012 · Dec 31, 2012 $511.09K
Capex restated FY 2012 · Dec 31, 2011 $542.81K
Operating Cash Flow restated FY 2012 · Dec 31, 2012 $1.5M
Operating Cash Flow restated FY 2012 · Dec 31, 2011 −$98.11K
Long Term Debt FY 2012 · Dec 31, 2012 $6.39M
Long Term Debt FY 2012 · Dec 31, 2011 $3.73M
Cash And Equivalents FY 2012 · Dec 31, 2012 $850.39K
Cash And Equivalents FY 2012 · Dec 31, 2011 $212.46K
Cash And Equivalents FY 2012 · Dec 31, 2010 $423
Stockholders Equity restated FY 2012 · Dec 31, 2012 $1.69M
Stockholders Equity restated FY 2012 · Dec 31, 2011 −$1.13M
Stockholders Equity FY 2012 · Dec 31, 2010 −$360.64K
Current Liabilities restated FY 2012 · Dec 31, 2012 $18.45M
Current Liabilities FY 2012 · Dec 31, 2011 $4.15M
Total Liabilities restated FY 2012 · Dec 31, 2012 $25.37M
Total Liabilities FY 2012 · Dec 31, 2011 $7.88M
Current Assets restated FY 2012 · Dec 31, 2012 $18.63M
Current Assets FY 2012 · Dec 31, 2011 $3.79M
Total Assets restated FY 2012 · Dec 31, 2012 $27.07M
Total Assets restated FY 2012 · Dec 31, 2011 $6.74M
Sga Expense restated FY 2012 · Dec 31, 2012 $9.49M
Sga Expense FY 2012 · Dec 31, 2011 $3.17M
Net Income restated FY 2012 · Dec 31, 2012 $82.3K
Net Income restated FY 2012 · Dec 31, 2011 −$1.61M
Operating Income restated FY 2012 · Dec 31, 2012 $544.38K
Operating Income restated FY 2012 · Dec 31, 2011 −$1.49M
Gross Profit restated FY 2012 · Dec 31, 2012 $14.07M
Gross Profit restated FY 2012 · Dec 31, 2011 $1.98M
Cost Of Revenue restated FY 2012 · Dec 31, 2012 $49.78M
Cost Of Revenue restated FY 2012 · Dec 31, 2011 $7.07M
Revenue restated FY 2012 · Dec 31, 2012 $63.85M
Revenue restated FY 2012 · Dec 31, 2011 $9.04M